WindRose Completes Sale of BPD Healthcare to MJH Life Sciences
WindRose Health Investors, the New York-based healthcare private equity firm, has completed the sale of BPD Healthcare to MJH Life Sciences, a leading medical media company in North America. The sale marks a significant moment for BPD, a technology-enabled marketing and communications partner to healthcare systems, care delivery enablers, and healthcare innovators. Over the past three years, BPD strengthened its go-to-market strategy, expanded its technology capabilities, and made several strategic hires to enhance its position as a trusted advisor to healthcare brands. The partnership between WindRose and BPD aimed to provide solutions to the most relevant challenges facing healthcare providers today.
Key Takeaways:
- WindRose Health Investors completed the sale of BPD Healthcare to MJH Life Sciences, a leading medical media company in North America.
- BPD Healthcare is a technology-enabled marketing and communications partner to healthcare systems, care delivery enablers, and healthcare innovators.
- WindRose completed a majority recapitalization of BPD in August 2022.
- CJ Burnes, Partner at WindRose, praised the partnership, stating, "We're excited to see how the combination with MJH Life Sciences will further accelerate BPD's impact on the broader healthcare industry."
- Jason Brown, Founder and CEO of BPD, expressed gratitude towards WindRose, saying, "Their support allowed us to go further, faster...by delivering more powerful solutions to our clients."
- McDermott Will & Schulte acted as legal advisor to WindRose, and Houlihan Lokey and William Blair acted as financial advisors.
- Day Pitney acted as legal advisor to MJH.
Statistics:
- BPD Healthcare provides fully integrated solutions, including branding, marketing, communications, and business consulting, which are technology-enabled, AI-infused, and supported by a proprietary data platform.
- WindRose has over $3.85 billion under management.
- The sale completes WindRose's investment in BPD Healthcare, which began with a majority recapitalization in August 2022.
Sources:
- PRNewswire, "WindRose Health Investors Completes Sale of BPD Healthcare to MJH Life Sciences."
- WindRose Health Investors, "About BPD"
- WindRose Health Investors, "About WindRose Health Investors"